The Future of Cancer Immunotherapy with Dr. James Allison

Sdílet
Vložit
  • čas přidán 27. 08. 2024

Komentáře • 13

  • @cndbrn7975
    @cndbrn7975 Před 2 lety +8

    Thanks for all the hard work, you're all doing a tremendous job

  • @andihidayat8309
    @andihidayat8309 Před 2 lety +6

    God Bless you Sir

  • @andyb5370
    @andyb5370 Před 4 lety +6

    CTLA-4 and PD-1 treatment has different subset of T cells .......you need to understand before treating cancer patients

    • @judjudersawn2596
      @judjudersawn2596 Před 4 lety +1

      time stamp?

    • @mpoharper
      @mpoharper Před 3 lety +2

      They are complimentary. They work better together than separately.

    • @billytheweasel
      @billytheweasel Před 2 lety

      @lt19611 I'm wondering why these drugs aren't used for breast cancer too.
      Anybody know???

    • @em34ev3r
      @em34ev3r Před 2 lety

      @@billytheweasel Yes they are. There are multiple clinical trials for CAR-T in solid tumors. Please research and find the best trial suited for you, it can save you or your loved ones life.

  • @billytheweasel
    @billytheweasel Před 2 lety +1

    Are there Monoclonal AntiBody medications that can be used for BREAST cancer yet?
    Grateful for this work...

  • @JV-cz6fz
    @JV-cz6fz Před 3 lety +3

    Hope this doesn't come across callous but research like this and the overall trajectory of how cancer treatment is moving is making me think that in about 50 years cancer is going to be a joke and will be more of a chronic condition that people don't really die from and most are "cured" from.

  • @alneal100
    @alneal100 Před 2 lety +1

    Does this treatment work for esophageal cancer?

  • @genesqaured2
    @genesqaured2 Před měsícem

    CTLA-4, Brake of T Cell